Gainers
Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial.
Agrify Corporation (NASDAQ: AGFY) announced the pricing of its underwritten public offering of (I) around 11.88 million common shares, and, in lieu of common stock to certain investors that so chose, pre-funded warrants to buy 1.5 million shares of its c
BILLERICA, Mass., Dec. 16, 2022 (GLOBE NEWSWIRE) -- Agrify Corporation (NASDAQ:AGFY) ("Agrify" or the "Company"), a leading provider of innovative cultivation and extraction solutions for the cannabis